Quest Diagnostics DGX
NYSE DGX
$246.50 -0.95 (-0.38%)
As of: Sep 18, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Cash from Operations Growth (1y) (2010 - 2026)

Analysis

Quest Diagnostics (DGX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 45.83%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.74%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -28.21%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 4.16%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -117.04%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn 290.74%
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 54.13%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn 672.93%
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 48.51%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 84.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.74%
Mar 31, 2026 -11.46%
Dec 31, 2025 0.22%
Sep 30, 2025 58.15%
Jun 30, 2025 51.11%
Mar 31, 2025 103.90%
Dec 31, 2024 -11.95%
Sep 30, 2024 71.98%
Jun 30, 2024 -18.92%
Mar 31, 2024 63.83%
Dec 31, 2023 57.78%
Sep 30, 2023 -58.76%
Jun 30, 2023 10.45%
Mar 31, 2023 -80.42%
Dec 31, 2022 -30.56%
Sep 30, 2022 -10.52%
Jun 30, 2022 -12.61%
Mar 31, 2022 -34.34%
Dec 31, 2021 -11.09%
Sep 30, 2021 -34.92%